OpenAlex
PricingAboutJobs
Log inGet started
Work

Imatinib and pegylated human recombinant interferon-α2b in early chronic-phase chronic myeloid leukemia

HTML PDF

Year: 2004
Type: article
Study design: Clinical Trial
Source: Blood
DOI: 10.1182/blood-2004-03-0826
Authors: Michele Baccarani, Giovanni Martinelli, Gianantonio Rosti, Elena Trabacchi, Nicoletta Testoni, Simona Bassi, Marilina Amabile, Simona Soverini, Fausto Castagnetti, Daniela Cilloni, Barbara Izzo, Antonio de Vivo, Emanuela Messa, Francesca Bonifazi, Angela Poerio, Simona Luatti, Emilia Giugliano, Daniele Alberti, Gianluca Fincato, Domenico Russo, Fabrizio Pane, Giuseppe Saglio, for the GIMEMA Working Party on Chronic Myeloid Leukemia
Institutions: Novartis (Italy), University of Turin, University of Naples Federico II, University of Brescia, University of Bologna
Language: English

Topic: Chronic Myeloid Leukemia Treatments
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: imatinib, peginterferon alfa-2b, chronic myeloid leukemia, early chronic phase, Philadelphia chromosome-positive leukemia, combination therapy, dose adjustment, adverse events, cytogenetic response, BCR-ABL transcript, treatment-naive patients
SDG: Good health and well-being

Open Access status: bronze
OpenAlex ID: W2131656137
FWCI: 6.495
Cites: 57
Cited by: 112
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security